Two COVID-19 patients who have been treated with the Israeli drug Opaganib have been showing signs of improvement after being on the drug for days.
The Jerusalem Post reported that the patients had moderate-to-severe symptoms of the virus and one of them was in the ICU; after being treated with Opaganib and hydroxychloroquine — the anti-malarial drug that President Donald Trump has touted — both patients saw “significant improvement.” The patient in the ICU was released after taking the medications.
